Antiplatelet therapy before, during, and after extremity revascularization

被引：9
作者：
Yang, Jane K. [1 ]
Jimenez, Juan Carlos [1 ]
Jabori, Sinan [1 ]
机构：
[1] Univ Calif Los Angeles, Div Vasc Surg, Los Angeles, CA 90095 USA
来源：
JOURNAL OF VASCULAR SURGERY | 2014年 / 60卷 / 04期
关键词：
AMERICAN-COLLEGE; CLOPIDOGREL; METAANALYSIS; ANGIOPLASTY; PREVENTION; THROMBOSIS; ASPIRIN; DISEASE; GRAFTS;
D O I：
10.1016/j.jvs.2014.07.006
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Peripheral arterial disease (PAD) is well recognized as a marker for systemic atherosclerosis. Platelets play an essential role in all stages of the disease, contributing to both thrombosis and the development of atherosclerosis. Medication regimens to optimize outcomes in both patients who are to undergo revascularization and those who will be managed without interventional therapy must address antiplatelet therapy. Given the common cardiovascular and cerebrovascular comorbidities in patients with PAD, antiplatelet therapy has the potential to decrease thromboembolic events in addition to improving patency after interventions. This clinical update reviews the current literature and recommendations for antiplatelet therapy in patients with PAD.
引用
收藏
页码：1085 / 1091
页数：7
相关论文
共 33 条
  • [1] Antithrombotic Therapy in Peripheral Artery Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Alonso-Coello, Pablo
    Bellmunt, Sergi
    McGorrian, Catherine
    Anand, Sonia S.
    Guzman, Randolph
    Criqui, Michael H.
    Akl, Elie A.
    Vandvik, Per Olav
    Lansberg, Maarten G.
    Guyatt, Gordon H.
    Spencer, Frederick A.
    [J]. CHEST, 2012, 141 (02) : E669S - E690S
  • [2] [Anonymous], COCHRANE DATABASE SY
  • [3] Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial
    Belch, Jill J. F.
    Dormandy, John
    [J]. JOURNAL OF VASCULAR SURGERY, 2010, 52 (04) : 825 - 833
  • [4] ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
    Bhatt, Deepak L.
    Scheiman, James
    Abraham, Neena S.
    Antman, Elliott M.
    Chan, Francis K. L.
    Furberg, Curt D.
    Johnson, David A.
    Mahaffey, Kenneth W.
    Quigley, Eamonn M.
    [J]. CIRCULATION, 2008, 118 (18) : 1894 - 1909
  • [5] Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
    Bonello, Laurent
    Laine, Marc
    Kipson, Nathalie
    Mancini, Julien
    Helal, Olfa
    Fromonot, Julien
    Gariboldi, Vlad
    Condo, Jocelyne
    Thuny, Franck
    Frere, Corinne
    Camoin-Jau, Laurence
    Paganelli, Franck
    Dignat-George, Francoise
    Guieu, Regis
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (09) : 872 - 877
  • [6] BROWN J, 2008, COCHRANE DB SYST REV, V4
  • [7] Patients with peripheral arterial disease in the CHARISMA trial
    Cacoub, Patrice P.
    Bhatt, Deepak L.
    Steg, P. Gabriel
    Topol, Eric J.
    Creager, Mark A.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 (02) : 192 - 201
  • [8] The role of platelets in peripheral vascular disease
    Cassar, K
    Bachoo, P
    Brittenden, J
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2003, 25 (01) : 6 - 15
  • [9] Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1
  • [10] Antiplatelet Drugs Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Eikelboom, John W.
    Hirsh, Jack
    Spencer, Frederick A.
    Baglin, Trevor P.
    Weitz, Jeffrey I.
    [J]. CHEST, 2012, 141 (02) : E89S - E119S
1234